U.S. Media Stock News

Why Rubrik stock is back in focus Rubrik (RBRK) is drawing fresh attention as analysts lift earnings estimates and highlight expected growth in subscription focused metrics, prompting investors to reassess the data security provider after recent share price volatility. See our latest analysis for Rubrik. The 1 month share price return of 6.40% and 7 day share price return of 4.83% suggest momentum has started to recover. However, the 90 day share price return of negative 33.95% and year to...

Auna (NYSE:AUNA) has wrapped up FY 2025 with Q4 revenue of S/1.1b and a basic EPS loss of S/0.86, while trailing twelve month EPS sits at S/1.32 on revenue of S/4.4b and net income of S/97.6m. Over recent quarters the company has seen revenue move from S/1.04b in Q1 2025 to S/1.09b in Q2, S/1.12b in Q3 and S/1.13b in Q4, with quarterly EPS ranging from S/0.49 in Q1 up to S/1.11 in Q2 and S/0.65 in Q3 before swinging to a loss in Q4, alongside a trailing net profit margin of 2.2%. For...

Clean Harbors' Safety-Kleen division reached a settlement with the U.S. EPA over environmental compliance issues tied to operations in New Jersey. The company has publicly committed to improved compliance, staff retraining, and facility upgrades as part of its response. Clean Harbors (NYSE:CLH) sits at the intersection of hazardous waste management, environmental services, and industrial cleaning, all of which are closely watched by regulators. The Safety-Kleen settlement puts a spotlight...

Stock performance snapshot Goldman Sachs Group (GS) has seen its share price move lower recently, with a 1 day return of 1.21%, about 5.01% over the past week, roughly 12.70% over the past month, and around 9.58% over the past 3 months. Even with these shorter term declines, the stock shows a 56.96% total return over the past year, around 183.98% over 3 years, and roughly 169.28% over 5 years. This gives investors a sense of how it has behaved across different time frames. See our latest...

Why IDT's latest earnings and dividend move matter for investors IDT (IDT) just reported Q2 results with higher revenue and net income than a year ago, lifted guidance for adjusted EBITDA, and raised its annual dividend, putting the stock firmly on investors' radar. See our latest analysis for IDT. Even with the stronger Q2 report and a higher dividend, IDT's share price has been choppy recently, with a 1 month share price return of 3.38% but a slightly negative year to date move. However,...

Wondering whether Zebra Technologies is attractively priced after a tough run, or if the risks still outweigh the potential reward? This article is aimed at helping you size up the value story in a clear, practical way. The stock last closed at US$213.67, with returns of 7.7% decline over the past week, 17.1% decline over the past month, 13.9% decline year to date, 23.5% decline over one year, 25.7% decline over three years and 54.9% decline over five years. These moves are likely to catch...

If you are wondering whether Fair Isaac's current share price actually lines up with its underlying worth, you are not alone. This article is built to help you assess that question clearly. The stock last closed at US$1,165.23, with a 20.4% decline over 7 days, a 15.1% decline over 30 days, a 29.1% decline year to date, but a 74.4% gain over 3 years and a 141.0% gain over 5 years. Recent attention on Fair Isaac has been driven by ongoing interest in credit scoring and decision analytics, as...

Shift4 Payments announced a major leadership reshuffle effective April 1, 2026, tied to its global expansion plans. Pier Francesco Nervini will become President of Shift4 International, overseeing all operations outside the Americas. Timothy Goodwin will take on the role of Chief Payments Officer, leading global payment technology. The Chief Accounting Officer is departing, with an international specialist stepping in on an interim basis. For investors watching NYSE:FOUR, this leadership...

What Just Happened With Blackstone Mortgage Trust? Blackstone Mortgage Trust (BXMT) has been drawing attention after a recent stretch of weak share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. For investors watching income oriented real estate finance names, this mixed picture, including positive 1 year and 3 year total returns alongside a 5 year total return decline, raises questions about how current fundamentals and...

If you are wondering whether Verizon Communications is still good value at around US$50.68 per share, you are not alone; many investors are asking the same question as the stock sits back on the radar. The share price closed at US$50.68 after a 1% decline over the last 7 days, while returns over the last 30 days, year to date and last year sit at 7.8%, 25.1% and 27.1% respectively. Recent coverage has focused on Verizon’s position within the US telecom sector, including how it is competing...

Caterpillar (NYSE:CAT) has entered a multi year global framework agreement with Atlas Energy to supply about 1.4 GW of power generation assets through 2029. The company has also launched a refreshed Cat Rentals digital platform, integrating Cat AI Assistant and a redesigned dashboard for equipment management. Both moves indicate that Caterpillar is expanding further into power and digital infrastructure alongside its traditional equipment business. Caterpillar is drawing investor attention...

JOYY (NasdaqGS:JOYY) has just wrapped up FY 2025 with fourth quarter revenue of US$581.9 million and basic EPS of US$20.84, capping a year in which trailing twelve month revenue came in at about US$2.1 billion and basic EPS on that basis reached US$797.28, supported by a US$1.9 billion one off gain earlier in the year. The company has seen quarterly revenue move from US$549.4 million in Q4 2024 to US$581.9 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$5.67 to a...

Agios Pharmaceuticals (AGIO) is back in focus after the Emirates Drug Establishment approved PYRUKYND for adult thalassemia patients in the UAE, alongside a NewBridge Pharmaceuticals deal to expand access across the Gulf Cooperation Council. See our latest analysis for Agios Pharmaceuticals. The PYRUKYND approvals in the Gulf region arrive after a mixed run for investors, with a 4.19% 1 month share price return to US$28.07, contrasted against a 12.23% 1 year total shareholder return decline...

With no single headline event driving attention today, Visa (V) is drawing interest after a stretch of weaker share performance, including a 10.6% decline over the past 3 months. See our latest analysis for Visa. Visa's recent weakness has come on top of a softer year to date, with a 1 day share price return of 1.74% decline and a year to date share price return of 10.83% decline. At the same time, the 3 year total shareholder return of 46.07% and 5 year total shareholder return of 43.72%...

In the past few months, BellRing Brands and several senior executives have been hit with multiple securities class action lawsuits alleging that earlier sales growth was artificially boosted by retailer inventory stockpiling rather than genuine consumer demand, and that competitive pressures and inventory adjustments were not fully disclosed to investors. These cases focus on whether management’s communications gave an accurate picture of underlying demand and retailer behavior, raising...

In early March 2026, analysts highlighted that First Solar’s 2026 outlook shows softer sales, a shrinking backlog and ongoing operational challenges, even as the company secured a new US$1.50 billion unsecured revolving credit facility and continues to benefit from policy incentives. A key concern emerging from these updates is how reliant First Solar’s strong margins are on Section 45X manufacturing tax credits, which are scheduled to phase out by 2033 and could materially affect future...

Finance of America Companies (FOA) just closed out FY 2025 with fourth quarter revenue of US$73.5 million and a basic EPS loss of US$1.26, following a year in which trailing twelve month EPS reached US$5.41 on revenue of US$497.4 million. The company has seen quarterly revenue move from US$290.1 million in Q3 2024 to US$73.5 million in Q4 2025, while basic EPS shifted from a profit of US$8.48 to a loss of US$1.26 over the same period. This sets up a mixed picture that investors will read...

ImmunityBio (IBRX) is back in focus after the FDA acknowledged receipt of the company’s resubmitted supplemental Biologics License Application for ANKTIVA plus BCG in BCG unresponsive non muscle invasive bladder cancer with papillary tumors. See our latest analysis for ImmunityBio. The FDA’s acknowledgement of the resubmitted ANKTIVA filing comes after a very strong 90 day share price return of 277.63% and a year-to-date share price return of 309.41%. However, the 7 day share price return of...

If you are wondering whether Solaris Energy Infrastructure is still reasonably priced after its strong run, this article will walk through what that current share price could imply about underlying value. The stock recently closed at US$55.35, with returns of 10.6% over 7 days, 4.5% over 30 days, 10.1% year to date, 122.1% over 1 year and a very large gain over 3 years that sits well above 7x, alongside a 352.8% return over 5 years. Recent price moves have come as Solaris Energy...

Judah Spinner’s BlackBird Financial recently increased its Builders FirstSource (BLDR) stake by a very large multiple after a sharp share price decline, signaling renewed interest despite ongoing weakness in the U.S. housing market. See our latest analysis for Builders FirstSource. That buying decision comes after a rough patch for the stock, with a 30 day share price return of 26.7% decline and a 1 year total shareholder return of 29.6% loss. However, the 5 year total shareholder return of...

YCG Investments and YCG LLC recently highlighted TransDigm Group as a key aerospace components supplier with resilient fundamentals across commercial and military aircraft platforms. Their commentary, alongside a rise in hedge fund ownership during the fourth quarter of 2025, points to strengthening institutional conviction in TransDigm’s business quality and positioning. Next, we’ll examine how this growing institutional interest might influence TransDigm’s investment narrative built around...

Oruka Therapeutics (ORKA) has begun an open-label extension Phase 2 trial of ORKA-001 in moderate to severe plaque psoriasis, evaluating long term safety, efficacy, and potentially convenient once yearly dosing schedules. See our latest analysis for Oruka Therapeutics. The latest ORKA-001 trial update comes after a strong run in the stock, with a year to date share price return of 19.17% and a 1 year total shareholder return above 200%. This suggests momentum has been building as investors...

TKO Group Holdings recently launched a US$800 million accelerated share repurchase and a US$200 million 10b5-1 plan, funded in part by a new US$900 million term loan and an expanded US$350 million revolving credit facility, while also declaring a US$0.78 per share quarterly dividend payable on March 31, 2026. These capital returns, layered on top of TKO’s ongoing share buyback completion and recent earnings update, highlight management’s focus on reducing the Class A share count while...

If you are looking at KLA and wondering whether the current share price still offers value, you are not alone. This article will help you frame that question clearly. KLA shares last closed at US$1,465, with returns of 1.7% over 30 days, 14.9% year to date and 117.0% over the past year, so it is understandable if you are questioning what is already priced in. Recent coverage of KLA has focused on its position in semiconductor process control equipment and how that exposure ties into long...